Galanin receptor (GALR2) binding assay
US6544753B1 · kind B1 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2000 |
| Grant date | Apr 8, 2003 |
| Priority date | — |
| Expiry date | Jul 24, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/72
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A new galanin receptor, GALR2, is described. Also provided are nucleic acids encoding same and various assays to identify ligands particular to said receptor. Ligands so identified are useful for the treatment of obesity, treatment of pain, and treatment of cognitive disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.